Borgio, J. F., Alsuwat, H. S., Al Otaibi, W. M., Ibrahim, A. M., Almandil, N. B., Al Asoom, L. I., . . . AbdulAzeez, S. (2020). State-of-the-art tools unveil potent drug targets amongst clinically approved drugs to inhibit helicase in SARS-CoV-2. Arch Med Sci.
Chicago Style CitationBorgio, J. Francis, Hind Saleh Alsuwat, Waad Mohammed Al Otaibi, Abdallah M. Ibrahim, Noor B. Almandil, Lubna Ibrahim Al Asoom, Mohammed Salahuddin, Balu Kamaraj, i Sayed AbdulAzeez. "State-of-the-art Tools Unveil Potent Drug Targets Amongst Clinically Approved Drugs to Inhibit Helicase in SARS-CoV-2." Arch Med Sci 2020.
Cita MLABorgio, J. Francis, et al. "State-of-the-art Tools Unveil Potent Drug Targets Amongst Clinically Approved Drugs to Inhibit Helicase in SARS-CoV-2." Arch Med Sci 2020.